Rumeysa Çolak | Oncologyst | Best Researcher Award

Posted on by ScienceFather

Dr. Rumeysa Çolak | Oncologyst | Best Researcher Award

Bakırköy Dr.Sadi Konuk Training and Research Hospital ,Turkey 🏆

Dr. Rumeysa Çolak is a dedicated Research Assistant at the Department of Medical Oncology, Training and Research Hospital in Istanbul, Turkey, she graduated from Inonu University Faculty of Medicine in July 2015. Passionate about medical research, Dr. Çolak’s professional interests focus on oncology, internal medicine, and the clinical application of various treatments. She is proficient in English and contributes to the medical community through case presentations, research articles, and poster presentations. Dr. Çolak has participated in multiple scientific events, particularly focusing on novel cancer treatments and the intersection between chronic diseases like diabetes and inflammatory bowel diseases. Her commitment to improving patient outcomes in complex cases has earned her respect in the field.

Profile

Scopus

Education 🎓

Dr. Rumeysa Çolak graduated from the Faculty of Medicine at Inonu University in July 2015, with a strong foundation in medical science. Her dedication to advancing her knowledge and skills led her to further her education, earning her a role as a Research Assistant in 2022 at the Training and Research Hospital’s Medical Oncology Department. Alongside her medical degree, Dr. Çolak achieved a proficiency score of 65 on the YDS (Foreign Language Exam) in 2014, showcasing her ability to work in both Turkish and English-speaking environments. Her focus on oncology and medical research reflects her academic drive and desire to contribute to advancing healthcare in Turkey. Dr. Çolak’s comprehensive training in medical research, patient care, and specialized oncology practices supports her role as a valuable asset to the medical community.

Experience 🏢

Dr. Rumeysa Çolak’s professional journey began with her graduation from Inonu University Faculty of Medicine in 2015. Following her medical degree, she gained experience working in various clinical settings before securing her current position as a Research Assistant in the Medical Oncology Department at a renowned Training and Research Hospital in Istanbul. Since joining in 2022, Dr. Çolak has actively contributed to oncology research and patient care, particularly focusing on treatments for complex conditions such as advanced melanoma and metabolic diseases. She has been involved in scientific events, including case presentations and research articles, further solidifying her role in the medical community. Dr. Çolak’s expertise spans clinical research, patient management, and treatment protocols, with an emphasis on improving patient outcomes in challenging cases, such as liver failure with encephalopathy and inflammatory bowel diseases.

Research Interests 🔬

Dr. Rumeysa Çolak’s research focuses on advancing knowledge in oncology, particularly in the treatment of advanced melanoma and other complex diseases. Her work investigates innovative therapies such as nivolumab in patients with BRAF mutant advanced melanoma. In addition to her focus on oncology, Dr. Çolak’s research spans areas like inflammatory bowel diseases (IBD), examining the prevalence of irritable bowel syndrome-like symptoms in patients with inactive IBD and their impact on quality of life. She is also interested in diabetes and its comorbidities, having researched the use of statins in Type 2 diabetes patients. Through her research, Dr. Çolak aims to contribute to understanding the molecular mechanisms of diseases, the impact of treatments on patient outcomes, and ways to improve quality of life for patients with chronic conditions. Her ongoing work holds promise for the development of new strategies for managing complex medical conditions.

Awards 🏅

Dr. Rumeysa Çolak has been recognized for her dedication and contributions to medical research and clinical practice. Throughout her academic and professional journey, she has participated in several prestigious scientific events and conferences. One notable achievement includes her involvement in the 55th National Diabetes Metabolism and Nutritional Diseases Congress in Cyprus, where she presented a poster on statin use in Type 2 diabetes mellitus patients. Additionally, Dr. Çolak’s research articles and case presentations have garnered attention in the medical community, contributing to the understanding of complex conditions like irritable bowel syndrome and melanoma treatment. While she has not yet received specific awards, Dr. Çolak’s commitment to advancing healthcare and her proactive involvement in scientific research position her as a rising star in the field of oncology and internal medicine.

Publications 📚

1. Association Between Baseline and Changes in Early Neutrophil-to-Lymphocyte Ratio on Survival in Patients with Metastatic Bladder Carcinoma Treated with Immunotherapy

2. ‘Statin Use and Objectives of The Target in Type 2 Diabetes Mellitus Patients: Is The Resistant in The Patient or The Physician?’

3. ‘Mutation in Complement Regulating Genes in Patients With Thrombotic Microangiopathic Resistant to Plasmapheresis Treatment’

4. ‘Assessment of Disease Activity by Fecal Occult Blood Test in Inflammatory Bowel Disease’

5. ‘Prevalence of Irritable Bowel Syndrome Like Symptoms in Patients With Inactive Inflammatory Bowel Disease and Relation With Quality of Life’

6. ‘A Case of Aggressive Prolactinoma’s Masked by HOOK Effect in Postmenopausal Period’

7. ‘Liver Transplantation Data of 20 Years Experience of Dokuz Eylul University Faculty of Medicine’

8. ‘Rare Gastric Metastasis of Breast Cancer’

Conclusion 🏅

Dr. Rumeysa Çolak is an excellent candidate for the “Best Researcher Award” given her diverse research portfolio, proven expertise, and significant impact in her field. She has demonstrated remarkable dedication to advancing both scientific knowledge and practical applications in oncology and chronic disease management. Her ongoing contributions to medical research and her ability to address complex health issues through innovative approaches underscore her suitability for such a prestigious recognition. Therefore, Dr. Çolak’s work makes her a strong contender for this award, and she deserves recognition for her excellence in research.

 

 

 

 

 

EVANKA MADAN | Cancer Biology | Best Researcher Award

Posted on by ScienceFather

Dr EVANKA MADAN | Cancer Biology | Best Researcher Award

Dr EVANKA MADAN, Sir Ganga Ram Hospital, India

Dr. Evanka Madan is a distinguished Consultant and Assistant Professor at Sir Ganga Ram Hospital, New Delhi, India. With a robust background in biochemistry and molecular biology, she has achieved significant acclaim in her field. Her research spans drug discovery for parasitic diseases, focusing on Leishmania and malaria. Dr. Madan has been recognized with numerous awards, including the Young Scientist Fellowship by ICMR-DHR and the Best Young Researcher Award at the Science Conclave cum NBRCOM. She has also made substantial contributions through international collaborations, including research stints at Albert Einstein College of Medicine, New York. Dr. Madan’s work has been featured in prominent journals, reflecting her commitment to advancing biomedical research and therapy.

Publication Profile

Scopus

Strengths for the Award

  1. Research Excellence: Dr. Madan’s research has significantly advanced our understanding of diseases like Leishmania and cardiovascular issues. Her work on identifying novel drug targets and mechanisms in infectious diseases and cancer demonstrates her high-impact research capabilities.
  2. Recognition and Awards: Dr. Madan has received numerous accolades, including the Young Scientist Fellowship from ICMR-DHR and several Best Paper and Poster Awards. This recognition underscores her contributions to the field and her potential for community impact.
  3. International Experience: Her research experience spans prestigious institutions globally, including Albert Einstein College of Medicine, and she has been involved in international conferences, enhancing her visibility and collaborative opportunities.
  4. Public Engagement: Dr. Madan has delivered public scientific lectures and talks at international conferences, demonstrating her commitment to communicating scientific knowledge to the broader community.
  5. Technical Proficiency: Her expertise in both molecular and computational biology equips her to address complex biological questions, further strengthening her research’s potential for community impact.

Areas for Improvement

  1. Community Outreach: While Dr. Madan’s research is highly specialized, further engagement with community-based projects and local health initiatives could amplify the direct benefits of her work to the general public.
  2. Application of Research Findings: Emphasizing how her research findings are translated into practical applications or interventions that directly benefit community health would strengthen her candidacy. Demonstrating more concrete examples of her research’s impact on public health policies or local health practices could be beneficial.
  3. Interdisciplinary Collaborations: Expanding collaborations beyond her immediate field could offer new perspectives and enhance the applicability of her research findings. Collaborations with social scientists or public health experts might enhance the community relevance of her work.

Education

Dr. Evanka Madan earned her PhD in Biochemistry from the All India Institute of Medical Sciences (AIIMS), New Delhi, in 2015. She completed her MSc in Medical Biotechnology from the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, in 2010, where she was the top-ranked student. Her undergraduate studies in Biological Sciences were completed at Sri Venkateshwara College, Delhi University, in 2008, securing third position. Her academic foundation is further supported by her early education at Delhi Public School, where she excelled in the CBSE curriculum.

Experience

Dr. Madan has extensive experience in biochemistry and molecular biology. As a Senior Scientist at Dhiti Life Sciences, she focused on recombinant antigens and monoclonal antibodies. Her role as a CSIR Scientist Pool Officer at Jawaharlal Nehru University involved investigating druggable targets in Leishmania. Previous roles include a Postdoctoral Fellowship at JNU, Research Associate positions at NII and IGIB, and a PhD tenure at AIIMS. Her research encompasses host-pathogen interactions, molecular characterization, and drug discovery, underscoring her expertise in parasitology and cancer biology.

Awards and Honors

Dr. Madan’s accolades include the prestigious Young Scientist Fellowship by ICMR-DHR (2021-24) and the Best Young Researcher Award at the Science Conclave cum NBRCOM, 2023. She has received multiple best presentation and poster awards at international conferences, such as the ICID Conference in Sydney and the National Congress of Parasitology. Additionally, she has been honored with travel grants from CSIR, ICMR, and DST for global conferences, highlighting her contributions to research and science communication.

Research Focus

Dr. Madan’s research primarily focuses on parasitic diseases, particularly Leishmania and malaria. Her work involves the molecular characterization of pathogen-host interactions, drug target identification, and pre-clinical evaluations. Recent studies explore the role of sphingosine kinase in Leishmania and the impact of arginine sensing in host-pathogen dynamics. Dr. Madan’s research also extends to cancer biology, with investigations into the FAT1 gene’s role in glioma and its influence on tumor biology and inflammation.

Publication Top Notes

Identification of a De Novo Peptide against Palmitoyl Acyltransferase 6 to Block Survivability and Infectivity of Leishmania donovani 🦠🔬

Screening of Traditional Medicinal Plant Extracts and Compounds Identifies a Potent Anti-Leishmanial Diarylheptanoid from Siphonochilus aethiopicus 🌿🦠

Targeting an Essential Plasmodium Cold Shock Protein to Block Growth and Transmission of Malaria Parasite 🦠💉

Cuscuta reflexa Possess Potent Inhibitory Activity Against Human Malaria Parasite: An In Vitro and In Vivo Study 🌿🦠

Host-Erythrocytic Sphingosine-1-Phosphate Regulates Plasmodium Histone Deacetylase Activity and Exhibits Epigenetic Control over Cell Death and Differentiation 🦠🧬

Rapid Diagnosis of Plasmodium falciparum Malaria Using a Point-of-Care Loop-Mediated Isothermal Amplification Device 🦠🔬

Host SUMOylation Pathway Negatively Regulates Protective Immune Responses and Promotes Leishmania donovani Survival 🦠🔬

Chromatin-Remodeling Factor BRG1 Is a Negative Modulator of L. donovani in IFNγ Stimulated and Infected THP-1 Cells 🦠🔬

Conclusion

Dr. Evanka Madan’s extensive research achievements, recognition in the field, and international experience position her as a strong candidate for the Research for Community Impact Award. Her work addresses critical health issues, and her expertise has the potential to significantly benefit community health. By enhancing her focus on community engagement and translating research into practical health solutions, she could further strengthen her impact. Overall, Dr. Madan’s contributions make her a commendable candidate for this award.